Physician profile
Bailey Murry
NPI 1447018924
$1,558.67
in general payments reported to CMS, 2019-2025
18 companies · $1,279 in 2025
The $1,279 reported for 2025 was more than what 92% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $280 · 2025: $1,279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,559.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,558.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $408.13 | 2024-2025 | Urolift |
| Medtronic, INC. | $355.80 | 2025 | Interstim |
| Dendreon Pharmaceuticals LLC | $199.83 | 2024-2025 | Provenge |
| Sumitomo Pharma America, INC. | $123.71 | 2024-2025 | Orgovyx, Gemtesa |
| Merck Sharp & Dohme LLC | $109.75 | 2025 | Keytruda, Lynparza, Keytruda Qlex |
| Janssen Biotech, INC. | $66.29 | 2025 | Erleada |
| C. R. Bard, INC. & Subsidiaries | $50.52 | 2025 | Magic3 Go Intermittent Urinary Catheter, Bard Urinary Drainage Bag |
| Endo USA, INC. | $47.06 | 2025 | Xiaflex |
| Astellas Pharma US INC | $34.17 | 2025 | Xtandi |
| Pfizer INC. | $22.94 | 2025 | |
| Verity Pharmaceuticals INC. | $21.81 | 2025 | Tlando |
| Azurity Pharmaceuticals, INC. | $20.17 | 2024 | Horizant |
| Accord Healthcare, INC. | $18.97 | 2024 | |
| Calyxo, INC. | $18.23 | 2024 | Cvac Aspiration System |
| Telix Pharmaceuticals | $17.66 | 2025 | Illuccix |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $17.31 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.19 | 2025 | |
| Laborie Medical Technologies Corp. | $11.13 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bailey Murry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.